Works matching IS 13518216 AND DT 2021 AND VI 27 AND IP 3
Results: 42
Issue Information.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. i, doi. 10.1111/hae.14267
- Publication type:
- Article
Plasma factor IX: The tip of the iceberg?
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 329, doi. 10.1111/hae.14324
- By:
- Publication type:
- Article
An evaluation of PROMIS health domains in adults with haemophilia: A cross‐sectional study.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 375, doi. 10.1111/hae.14321
- By:
- Publication type:
- Article
Emicizumab prophylaxis: Prospective longitudinal real‐world follow‐up and monitoring.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 383, doi. 10.1111/hae.14318
- By:
- Publication type:
- Article
Validation of factor VIII activity for monitoring standard and extended half‐life products and correlation to thrombin generation assays.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 494, doi. 10.1111/hae.14317
- By:
- Publication type:
- Article
Observational study of efficacy and safety of human cell line–derived recombinant factor VIII in Canadian adults with moderately severe and severe haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e419, doi. 10.1111/hae.14310
- By:
- Publication type:
- Article
Confirmed long‐term safety and efficacy of prophylactic treatment with BAY 94–9027 in severe haemophilia A: final results of the PROTECT VIII extension study.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e347, doi. 10.1111/hae.14297
- By:
- Publication type:
- Article
Haemophilia A patients' medication adherence to prophylaxis with efmoroctocog alfa.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e368, doi. 10.1111/hae.14301
- By:
- Publication type:
- Article
The Function of extravascular coagulation factor IX in haemostasis.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 332, doi. 10.1111/hae.14300
- By:
- Publication type:
- Article
Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B‐NORD study.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 366, doi. 10.1111/hae.14299
- By:
- Publication type:
- Article
Pathological coagulation parameters in as many as 54 patients with autoimmune acquired factor XIII deficiency due to anti–factor XIII autoantibodies.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 454, doi. 10.1111/hae.14298
- By:
- Publication type:
- Article
Ultrasound and magnetic resonance imaging for the detection of blood: An ex‐vivo study.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 488, doi. 10.1111/hae.14303
- By:
- Publication type:
- Article
Challenges of antithrombotic therapy in the management of cardiovascular disease in patients with inherited bleeding disorders: A single‐centre experience.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 425, doi. 10.1111/hae.14296
- By:
- Publication type:
- Article
A comparison of MyPKFiT and WAPPS‐Hemo as dosing tools for optimizing prophylaxis in patients with severe haemophilia A treated with Octocog alfa.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 417, doi. 10.1111/hae.14295
- By:
- Publication type:
- Article
PROTECT VIII kids extension study: Long‐term safety and efficacy of BAY 94‐9027 (damoctocog alfa pegol) in children with severe haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 434, doi. 10.1111/hae.14294
- By:
- Publication type:
- Article
Pharmacokinetic implications of dosing emicizumab based on vial size: A simulation study.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 358, doi. 10.1111/hae.14292
- By:
- Publication type:
- Article
Recombinant FVIIa in elective non‐orthopaedic surgery of adults with haemophilia and inhibitors: A systematic literature review.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e314, doi. 10.1111/hae.14291
- By:
- Publication type:
- Article
Limited sampling strategies for accurate determination of extended half‐life factor VIII pharmacokinetics in severe haemophilia A patients.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 408, doi. 10.1111/hae.14288
- By:
- Publication type:
- Article
Factor VIII concentrate dosing with lean body mass, ideal body weight and total body weight in overweight and obesity: A randomized, controlled, open‐label, 3 × 3 crossover trial.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 351, doi. 10.1111/hae.14285
- By:
- Publication type:
- Article
Effects of a non‐pharmacological approach for chronic pain management in patients with haemophilia: efficacy of cognitive‐behavioural therapy associated with physiotherapy.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e357, doi. 10.1111/hae.14284
- By:
- Publication type:
- Article
Health‐related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors—A non‐interventional study.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 398, doi. 10.1111/hae.14270
- By:
- Publication type:
- Article
Ultrasound evaluation of joint damage and disease activity in adult patients with severe haemophilia A using the HEAD‐US system.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 479, doi. 10.1111/hae.14280
- By:
- Publication type:
- Article
Evaluating the effectiveness of let's talk period's high school educational outreach program: A pilot study.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 470, doi. 10.1111/hae.14277
- By:
- Publication type:
- Article
Pharmacokinetic study of Kovaltry in thirty‐five pediatric patients aged <12 years with severe hemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e340, doi. 10.1111/hae.14276
- By:
- Publication type:
- Article
Recurrent intracranial bleed in a child receiving prophylaxis with emicizumab.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e415, doi. 10.1111/hae.14274
- By:
- Publication type:
- Article
The effects of manual therapy and exercises on pain, muscle strength, joint health, functionality and quality of life in haemophilic arthropathy of the elbow joint: A randomized controlled pilot study.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e376, doi. 10.1111/hae.14281
- By:
- Publication type:
- Article
The effect of age at diagnosis of type 1 von Willebrand disease on diagnostic laboratory values: A paediatric perspective.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e412, doi. 10.1111/hae.14265
- By:
- Publication type:
- Article
Occurrence rates of von Willebrand disease among people receiving care in specialized treatment centres in the United States.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 445, doi. 10.1111/hae.14263
- By:
- Publication type:
- Article
Characterization of a plasma‐derived double−viral‐inactivated factor VIII concentrate (antihaemophilic factor [human]): Focus on TTP treatment.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e409, doi. 10.1111/hae.14260
- By:
- Publication type:
- Article
A rare case of long‐term complications of squamous cell carcinoma in haemophilia B after arthrocentesis, and review of the literature.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e406, doi. 10.1111/hae.14255
- By:
- Publication type:
- Article
Sports participation is not associated with adherence to prophylaxis in Dutch patients with haemophilia.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e402, doi. 10.1111/hae.14244
- By:
- Publication type:
- Article
Spontaneous intracranial haemorrhage as initial presentation of haemophilia in infants and children: A case report and systematic literature review.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e398, doi. 10.1111/hae.14239
- By:
- Publication type:
- Article
Correction of haemostasis can be reduced to four days for CVAD implantation in severe haemophilia A patients: Data from the PedNet study group.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 392, doi. 10.1111/hae.14231
- By:
- Publication type:
- Article
Consecutive complex percutaneous coronary interventions using emicizumab and recombinant activated factor VII in a patient with severe haemophilia A and high‐titre inhibitor.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e385, doi. 10.1111/hae.14165
- By:
- Publication type:
- Article
Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e331, doi. 10.1111/hae.14219
- By:
- Publication type:
- Article
Immune tolerance induction with antihaemophilia factor (human) in poor prognosis patients with haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e393, doi. 10.1111/hae.14175
- By:
- Publication type:
- Article
Measuring factor VIII activity in samples from patients treated with N8‐GP (Esperoct<sup>®</sup>; turoctocog alfa pegol) during the pathfinder clinical trials programme.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e389, doi. 10.1111/hae.14173
- By:
- Publication type:
- Article
Practical considerations for nonfactor‐replacement therapies in the treatment of haemophilia with inhibitors.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 340, doi. 10.1111/hae.14167
- By:
- Publication type:
- Article
Managing women‐specific bleeding in inherited bleeding disorders: A multidisciplinary approach.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 463, doi. 10.1111/hae.14221
- By:
- Publication type:
- Article
Factor VIII/IX inhibitor testing practices in the United Kingdom: Results of a UKHCDO and UKNEQAS national survey.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 490, doi. 10.1111/hae.14158
- By:
- Publication type:
- Article
Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panel.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e305, doi. 10.1111/hae.14010
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. i, doi. 10.1111/hae.14267
- Publication type:
- Article